Inhibition of GDNF-Driven Macrophage-to-Myofibroblast Transition Protects Against Colitis-Associated Intestinal Fibrosis
Inflammation · 2024
DOI: 10.1007/s10753-024-02175-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammation, 2024. Verfasst von Jian Zeng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China. zengjianhuaxi@163.com. Hauptthemen laut MEDLINE: Glial Cell Line-Derived Neurotrophic Factor, Myofibroblasts, Macrophages, Colitis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Glial cell line-derived neurotrophic factor (GDNF) has been demonstrated to promote the development of liver fibrosis, but its role in intestinal fibrosis is unknown. Macrophage-to-myofibroblast transition (MMT) is an important pathway contributing to fibrosis diseases. However, whether MMT cells, characterized by co-expressing both macrophage (CD68 or F4/80) and myofibroblast (α-SMA) markers, occurs in intestinal fibrosis remain to be addressed. Here, we showed that GDNF expression and the infiltration of MMT cells in intestinal tissues from patients with fibrostenotic Crohn's disease (CD) and a mouse model of chronic dextran sodium salt-induced intestinal fibrosis were significantly increased. GDNF induced bone marrow-derived macrophages (BMDMs) differentiation into MMT cells in vitro. Mechanistically, the Src pathway was activated by GDNF stimulation and contributed to GDNF-induced MMT in BMDMs. Moreover, pharmacological inhibition of GDNF by using antibody markedly decreased the infiltration of MMT cells following the decrease of collagen deposition and α-SMA and Col1 expression in the mouse model of colitis-associated intestinal fibrosis. In conclusion, GDNF is able to induce MMT and contributes to intestinal fibrosis in the context of chronic intestinal inflammation. Pharmacological inhibition of GDNF-driven MMT might provide a novel approach for the treatment of fibrosis complication in CD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China. zengjianhuaxi@163.com.
- Department of Gastroenterology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China.
- Department of Gastroenterology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China. yangxiaojungasro@126.com.
Zitieren
APA
Zeng, J., Du, X. L., Lu, Q. Q., Chen, W. Q., & Yang, X. J. (2024). Inhibition of GDNF-Driven Macrophage-to-Myofibroblast Transition Protects Against Colitis-Associated Intestinal Fibrosis. Inflammation. https://doi.org/10.1007/s10753-024-02175-3
Vancouver
Zeng J, Du XL, Lu QQ, Chen WQ, Yang XJ. Inhibition of GDNF-Driven Macrophage-to-Myofibroblast Transition Protects Against Colitis-Associated Intestinal Fibrosis. Inflammation. 2024. doi:10.1007/s10753-024-02175-3
BibTeX
@article{Zeng2024,
author = {Zeng, Jian and Du, Xiao-Long and Lu, Qiong-Qiong and Chen, Wan-Qun and Yang, Xiao-Jun},
title = {Inhibition of GDNF-Driven Macrophage-to-Myofibroblast Transition Protects Against Colitis-Associated Intestinal Fibrosis},
journal = {Inflammation},
year = {2024},
doi = {10.1007/s10753-024-02175-3}
}
EUVIMED